RankAlpha logo
Back to Rankings

FULC

Fulcrum TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
FULC vs peer average
46/100
FULC vs. peer average (D vs. D)
Grade spread
C 4 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MYGN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $291.73M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMYGNMyriad Genetics
FULC
Fulcrum Therapeutics
MYGN
Myriad Genetics
Grade
D
C
Momentum
10
2
Value
58
41
Sentiment
-
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs MYGN

FULC / MYGN
Grade Position
In line
FULC vs. peer average (D vs. D)
46/100
Momentum
10
FULC
Value
58
FULC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FULC
1
MYGN
Myriad Genetics Inc Common
C
60/100
-1
2
AMRN
Amarin Corporation Plc ADR
C
60/100
-1
3
ELDN
Eledon Pharmaceuticals Inc Common
F
20/100
+1
4
TTRX
Turn Therapeutics Inc Common
F
20/100
+1
5
AVXL
Anavex Life Sciences Corp Common
D
40/100
Even
MYGN is the first peer returned for this comparison set.